Per Soelberg Sørensen

Per Soelberg Sørensen

Professor emeritus, Professor, emeritus


  1. 2013
  2. Published

    Prolonged-release fampridine improves walking in a proportion of patients with multiple sclerosis

    Mathiesen, H. K. & Sørensen, Per Soelberg, 2013, In: Expert Review of Neurotherapeutics. 13, 12, p. 1309-1317 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Reproduction and the risk of multiple sclerosis

    Magyari, M., Koch-Henriksen, N. I., Pfleger, C. C. & Sørensen, Per Soelberg, 2013, In: Multiple Sclerosis. 19, 12, p. 1604-1609 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression

    Romme Christensen, J., Börnsen, L., Ratzer, R., Piehl, F., Khademi, M., Olsson, T., Sørensen, Per Soelberg & Sellebjerg, Finn Thorup, 2013, In: P L o S One. 8, 3, p. 1-11 11 p., e57820.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    lægenotat vedrørende magtanvendelsesgrebet brystvendt benlås

    Lauritzen, Jes Bruun, Eskesen, V., Sørensen, Per Soelberg & nielsen, F., 2013

    Research output: Book/ReportReportResearchpeer-review

  6. 2012
  7. Published

    Chronic cerebrospinal venous insufficiency and venous stenoses in multiple sclerosis

    Blinkenberg, M., Akeson, P., Sillesen, H., Lövgaard, S., Sellebjerg, Finn Thorup, Paulson, Olaf B., Siebner, H. R. & Sørensen, Per Soelberg, Dec 2012, In: Acta Neurologica Scandinavica. 126, 6, p. 421-7 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Quantification of independent cervical spinal cord atrophy measures correlate to motor and sensory deficits in MS

    Garde, E., Lundell, H., Dogonowski, A., Gude, S., Hanne, S., Sørensen, Per Soelberg, Blinkenberg, M. B. & Siebner, H. R., 12 Oct 2012. 0 p.

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  9. Published

    Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosis

    Sellebjerg, Finn Thorup, Hesse, D., Limborg, S., Lund, H., Søndergaard, H., Krakauer, M. & Sørensen, Per Soelberg, Feb 2012, In: Multiple Sclerosis. 19, 2, p. 179-87 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Cerebral metabolism, magnetic resonance spectroscopy and cognitive dysfunction in early multiple sclerosis: an exploratory study

    Blinkenberg, M., Mathiesen, H. K., Tscherning, T., Jønsson, A., Svarer, C., Holm, S., Sellebjerg, Finn Thorup, Paulson, Olaf B., Hanson, L. G. & Sørensen, Per Soelberg, Jan 2012, In: Neurological Research. 34, 1, p. 52-8 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Akut medicin og neurologi

    Feldt-Rasmussen, Ulla & Sørensen, Per Soelberg, 2012, Medicin. Lærebog i medicin. Baslund, B., Feldt-Rasmussen, U., Kastrup, J. & Soelberg Sørensen, P. (eds.). 1. ed. p. 1142-1173 31 p.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

  12. Published

    Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

    Coles, A. J., Twyman, C. L., Arnold, D. L., Cohen, J. A., Confavreux, C., Fox, E. J., Hartung, H., Havrdova, E., Selmaj, K. W., Weiner, H. L., Miller, T., Fisher, E., Sandbrink, R., Lake, S. L., Margolin, D. H., Oyuela, P., Panzara, M. A., Compston, D. A. S., CARE-MS II investigators, C. I. I. & Sørensen, Per Soelberg, 2012, In: Lancet. 380, 9856, p. 1829-39 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. Published

    Assess, compare and enhance the status of Persons with Multiple Sclerosis (MS) in Europe: a European Register for MS

    Pugliatti, M., Eskic, D., Mikolcić, T., Pitschnau-Michel, D., Myhr, K-M., Sastre-Garriga, J., Otero, S., Wieczynska, L., Torje, C., Holloway, E., Rienhoff, O., Friede, T., Buckow, K., Ellenberger, D., Hillert, J., Glaser, A-M. S., Flachenecker, P., Fuge, J., Schyns-Liharska, T., Kasilingam, E. & 4 others, Moretti, A., Thalheim, C., EUReMS Consortium, E. C. & Sørensen, Per Soelberg, 2012, In: Acta Neurologica Scandinavica. Supplementum. 126, 195, p. 24-30 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  14. Published

    Association between DPP6 polymorphism and the risk of progressive multiple sclerosis in Northern and Southern Europeans

    Brambilla, P., Esposito, F., Lindstrom, E., Sorosina, M., Giacalone, G., Clarelli, F., Rodegher, M., Colombo, B., Moiola, L., Ghezzi, A., Capra, R., Collimedaglia, L., Coniglio, G., Celius, E. G., Galimberti, D., Sørensen, P. S., Martinelli, V., Oturai, A. B., Harbo, H. F., Hillert, J. & 2 others, Comi, G. & Martinelli-Boneschi, F., 2012, In: Neuroscience Letters. 530, 2, p. 155-60 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  15. Published

    Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis

    Romme Christensen, J., Börnsen, L., Hesse, D., Krakauer, M., Sørensen, Per Soelberg, Søndergaard, H. B. & Sellebjerg, Finn Thorup, 2012, In: Journal of Neuroinflammation. 9, p. 215

    Research output: Contribution to journalJournal articleResearchpeer-review

  16. Published

    Cognitive deficits in multiple sclerosis: correlations with T2 changes in normal appearing brain tissue

    Lund, H., Jønsson, A., Andresen, J. G., Rostrup, E., Paulson, Olaf B. & Sørensen, Per Soelberg, 2012, In: Acta Neurologica Scandinavica. 125, 5, p. 338-44 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  17. Published

    Correlation between anti-interferon-β binding and neutralizing antibodies in interferon-β-treated multiple sclerosis patients

    Jensen, P. E. H., Sellebjerg, Finn Thorup, Søndergaard, H. B. & Sørensen, Per Soelberg, 2012, In: European Journal of Neurology. 19, 10, p. 1311-7 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  18. Published

    Deaths and disability from natalizumab are no longer tolerable: No - (they can be avoided)

    Sørensen, Per Soelberg, 2012, In: Multiple Sclerosis. 18, 8, p. 1070-2 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  19. Published

    Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects

    Cohen, J. A., Reingold, S. C., Polman, C. H., Wolinsky, J. S., International Advisory Committee on Clinical Trials in Multiple Sclerosis, I. A. C. O. C. T. I. M. S. & Sørensen, Per Soelberg, 2012, In: Lancet Neurology. 11, 5, p. 467-76 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  20. Published

    Dødsfald i forbindelse med tvangsfastholdelse af svært agiterede personer bør kunne undgås

    Sørensen, Per Soelberg, 2012, In: Ugeskrift for Laeger. 174, 40, p. 2367

    Research output: Contribution to journalJournal articleResearchpeer-review

  21. Published

    Effect of Natalizumab on Circulating CD4(+) T-Cells in Multiple Sclerosis

    Börnsen, L., Christensen, J. R., Ratzer, R., Oturai, A. B., Sørensen, Per Soelberg, Søndergaard, H. B. & Sellebjerg, Finn Thorup, 2012, In: P L o S One. 7, 11, p. e47578

    Research output: Contribution to journalJournal articleResearchpeer-review

  22. Published

    Effects of neutralizing antibodies to interferon beta in multiple sclerosis: a logical paradox

    Sørensen, Per Soelberg, 2012, In: Multiple Sclerosis. 18, 2, p. 131-2 2 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  23. Published

    Endogenous and recombinant type I interferons and disease activity in multiple sclerosis

    Sellebjerg, Finn Thorup, Krakauer, M., Limborg, S., Hesse, D., Lund, H., Langkilde, Annika Reynberg, Søndergaard, H. B. & Sørensen, Per Soelberg, 2012, In: P L o S One. 7, 6, p. e35927

    Research output: Contribution to journalJournal articleResearchpeer-review

  24. Published

    FOXP3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD4(+) CD25(high) T cells in multiple sclerosis

    Sellebjerg, Finn Thorup, Krakauer, M., Khademi, M., Olsson, T. & Sørensen, Per Soelberg, 2012, In: Clinical and Experimental Immunology. 170, 2, p. 149-55 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  25. Published

    Ny simplere diagnosticering af multipel sklerose

    Mathiesen, H. K. & Sørensen, Per Soelberg, 2012, In: Ugeskrift for Laeger. 174, 13, p. 862-5 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  26. Published

    Prediction of antibody persistency from antibody titres to natalizumab

    Jensen, P. E. H., Koch-Henriksen, N., Sellebjerg, Finn Thorup & Sørensen, Per Soelberg, 2012, In: Multiple Sclerosis. 18, 10, p. 1493-9 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  27. Published

    Reduction in Healthcare and Societal Resource Utilization Associated with Cladribine Tablets in Patients with Relapsing-Remitting Multiple Sclerosis: Analysis of Economic Data from the CLARITY Study

    Ali, S., Paracha, N., Cook, S., Giovannoni, G., Comi, G., Rammohan, K., Rieckmann, P., Sørensen, Per Soelberg, Vermersch, P., Greenberg, S., Scott, D. A. & Joyeux, A., 2012, In: Clinical Drug Investigation. 32, 1, p. 15-27 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 11025